← Every lobbying firm
Todd Strategy Group
A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as TODD STRATEGY GROUP.
Clients
25
named in its filings
Filings
44
2026
Fees reported
$2.7M
across every filing
Who it represents
Largest first, by what the filings report being paid.
| Client | Fees |
|---|---|
| Eli Lilly And CompanyEli Lilly and Co | $160K |
| Compass Pathways Inc.Compass Inc | $160K |
| Illumina, Inc.Illumina Inc | $160K |
| Astrazeneca Pharmaceuticals LPAstraZeneca PLC | $160K |
| Guardant Health, Inc.Guardant Health Inc | $160K |
| Bristol-Myers Squibb CompanyBristol-Myers Squibb Co | $130K |
| Alkermes, Inc.Alkermes Plc | $120K |
| Caredx, Inc.CareDx Inc | $120K |
| Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals Inc | $120K |
| Apollo Global ManagementApollo Global Management Inc | $120K |
| Insulet CorporationInsulet Corp | $120K |
| Siemens HealthineersSiemens Healthineers AG | $120K |
| Pfizer Inc.Pfizer Inc | $120K |
| Takeda Pharmaceuticals America, Inc.Takeda Pharmaceutical Co Ltd | $100K |
| Otsuka America Pharmaceutical, Inc.Otsuka Holdings Co Ltd | $100K |
| Astellas Pharma US, Inc.Astellas Pharma Inc | $100K |
| Exelixis, Inc.Exelixis Inc | $100K |
| McKesson CorporationMcKesson Corp | $100K |
| Biogen, Inc.Biogen Inc | $100K |
| Gilead Sciences, Inc.Gilead Sciences, Inc | $80K |
| Amgen Inc.Amgen Inc | $80K |
| Novo Nordisk Inc.Novo Nordisk A/S | $60K |
| Fox CorporationFox Corp | $50K |
| Merck & Co., Inc.Merck & Co Inc | $50K |
| Pearson Education, Inc.Pearson PLC | $10K |
Every filing
Newest first, and within a year the largest.
| Client | Fee |
|---|---|
| Eli Lilly And Company | $80K |
| Compass Pathways Inc. | $80K |
| Illumina, Inc. | $80K |
| Bristol-Myers Squibb Company | $80K |
| Astrazeneca Pharmaceuticals LP | $80K |
| Guardant Health, Inc. | $80K |
| Illumina, Inc. | $80K |
| Eli Lilly And Company | $80K |
| Guardant Health, Inc. | $80K |
| Gilead Sciences, Inc. | $80K |
| Amgen Inc. | $80K |
| Compass Pathways Inc. | $80K |
| Astrazeneca Pharmaceuticals LP | $80K |
| Alkermes, Inc. | $60K |
| Caredx, Inc. | $60K |
| Alkermes, Inc. | $60K |
| Alnylam Pharmaceuticals, Inc. | $60K |
| Alnylam Pharmaceuticals, Inc. | $60K |
| Apollo Global Management | $60K |
| Insulet Corporation | $60K |
| Siemens Healthineers | $60K |
| Novo Nordisk Inc. | $60K |
| Insulet Corporation | $60K |
| Pfizer Inc. | $60K |
| Pfizer Inc. | $60K |
| Siemens Healthineers | $60K |
| Apollo Global Management | $60K |
| Caredx, Inc. | $60K |
| Bristol-Myers Squibb Company | $50K |
| Takeda Pharmaceuticals America, Inc. | $50K |
| Otsuka America Pharmaceutical, Inc. | $50K |
| Astellas Pharma US, Inc. | $50K |
| Takeda Pharmaceuticals America, Inc. | $50K |
| Exelixis, Inc. | $50K |
| Fox Corporation | $50K |
| McKesson Corporation | $50K |
| Biogen, Inc. | $50K |
| Merck & Co., Inc. | $50K |
| Exelixis, Inc. | $50K |
| Astellas Pharma US, Inc. | $50K |
| Otsuka America Pharmaceutical, Inc. | $50K |
| McKesson Corporation | $50K |
| Biogen, Inc. | $50K |
| Pearson Education, Inc. | $10K |
Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.